Our findings are in agreement with those of Lo et al. [28], who indicated that in a non-small cell lung cancer cell line (A549) some anthracyclines and their derivatives, like aclarubicin, modulate the functionality of P-gp. The gene discussed is PGP; the disease is non-small cell lung carcinoma.